Literature DB >> 12925608

Negative regulation of BMP signaling by the ski oncoprotein.

Kunxin Luo1.   

Abstract

The bone morphogenetic proteins (BMPs) play important roles in the regulation of multiple aspects of vertebrate development. BMPs signal through the cell surface receptors and downstream Smad molecules. Upon stimulation with BMP, Smad1, Smad5, and Smad8 are phosphorylated by the activated BMP receptors, form a complex with Smad4, and translocate into the nucleus, where they regulate the expression of BMP target genes. The activity of this signal pathway can be modulated both by extracellular factors that regulate the binding of BMPs to the receptor and by intracellular proteins that interact with the Smad proteins. We have shown that Ski is an important negative regulator of the Smad proteins. Ski can bind to the BMP-Smad protein complexes in response to BMP and repress their ability to activate BMP target genes through disruption of a functional Smad complex and through recruitment of transcriptional co-repressors. The antagonism of BMP signaling by Ski results in neural specification in Xenopus embryos and inhibition of osteoblast differentiation in mouse bone-marrow stromal progenitor cells. This ability to modulate BMP signaling by Ski may play an important role in the regulation of craniofacial, neuronal, and skeletal muscle development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925608     DOI: 10.2106/00004623-200300003-00008

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  9 in total

Review 1.  Bone morphogenetic proteins and their antagonists.

Authors:  Elisabetta Gazzerro; Ernesto Canalis
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

Review 2.  Dynamic signaling for neural stem cell fate determination.

Authors:  Shu Wen; Hong Li; Jia Liu
Journal:  Cell Adh Migr       Date:  2009-01-10       Impact factor: 3.405

3.  Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.

Authors:  Kyung-Ok Kim; Erik R Sampson; Robert D Maynard; Regis J O'Keefe; Di Chen; Hicham Drissi; Randy N Rosier; Matthew J Hilton; Michael J Zuscik
Journal:  J Cell Biochem       Date:  2012-06       Impact factor: 4.429

Review 4.  Bone morphogenetic protein signaling in musculoskeletal cancer.

Authors:  Myrto Bami; Andreas F Mavrogenis; Andrea Angelini; Mandy Milonaki; Evanthia Mitsiokapa; Dimitrios Stamoulis; Panayotis N Soucacos
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-04       Impact factor: 4.553

Review 5.  Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy.

Authors:  SongTing Shi; David J J de Gorter; Willem M H Hoogaars; Peter A C 't Hoen; Peter ten Dijke
Journal:  Cell Mol Life Sci       Date:  2012-07-04       Impact factor: 9.261

6.  Nestin-GFP transgene reveals neural precursor cells in adult skeletal muscle.

Authors:  Alexander Birbrair; Zhong-Min Wang; Maria Laura Messi; Grigori N Enikolopov; Osvaldo Delbono
Journal:  PLoS One       Date:  2011-02-03       Impact factor: 3.240

7.  Induction of Ski Protein Expression upon Luteinization in Rat Granulosa Cells.

Authors:  Hyun Kim; Dong Hun Kim; Soo Bong Park; Yeoung-Gyu Ko; Sung-Woo Kim; Yoon Jun Do; Jae-Hong Park; Boh-Suk Yang
Journal:  Asian-Australas J Anim Sci       Date:  2012-05-01       Impact factor: 2.509

Review 8.  Epigenetic Modulation of Stem Cells in Neurodevelopment: The Role of Methylation and Acetylation.

Authors:  Martyna Podobinska; Ilona Szablowska-Gadomska; Justyna Augustyniak; Ioanna Sandvig; Axel Sandvig; Leonora Buzanska
Journal:  Front Cell Neurosci       Date:  2017-02-07       Impact factor: 5.505

9.  Structural basis for receptor-regulated SMAD recognition by MAN1.

Authors:  Ken-Ichi Miyazono; Yosuke Ohno; Hikaru Wada; Tomoko Ito; Yui Fukatsu; Akira Kurisaki; Makoto Asashima; Masaru Tanokura
Journal:  Nucleic Acids Res       Date:  2018-12-14       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.